1. Home
  2. MG vs MRVI Comparison

MG vs MRVI Comparison

Compare MG & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

HOLD

Current Price

$17.33

Market Cap

481.7M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$4.82

Market Cap

559.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MG
MRVI
Founded
1978
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.7M
559.0M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
MG
MRVI
Price
$17.33
$4.82
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
169.4K
2.6M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
0.07
N/A
Revenue
$700,970,000.00
$185,743,000.00
Revenue This Year
$5.47
$12.54
Revenue Next Year
$3.59
$7.87
P/E Ratio
$251.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.38
$1.99
52 Week High
$19.56
$5.00

Technical Indicators

Market Signals
Indicator
MG
MRVI
Relative Strength Index (RSI) 50.84 68.22
Support Level $16.40 $3.27
Resistance Level $19.46 $5.00
Average True Range (ATR) 0.67 0.25
MACD -0.04 0.01
Stochastic Oscillator 56.63 81.91

Price Performance

Historical Comparison
MG
MRVI

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: